Chris Marlett
Chief Executive Officer at MDB CAPITAL HOLDINGS, LLC
Net worth: 35 M $ as of 2024-04-29
Profile
Christopher Anthony Marlett is the founder of PatentVest, Inc. (founded in 2003), Public Ventures LLC (founded in 1997), and MDB Capital Holdings LLC (founded in 1997).
He is currently a Director at Invizyne Technologies, Inc. (since 2019).
He has also held positions as a Director at Orion Acquisition Corp.
II, The Arena Group Holdings, Inc., and Cue Biopharma, Inc. Mr. Marlett obtained his undergraduate degree from the University of Southern California in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MDB CAPITAL HOLDINGS LLC
75.10% | 2024-03-28 | 3,755,000 ( 75.10% ) | 34 M $ | 2024-04-29 |
| 2024-03-28 | 79,933 ( 1.86% ) | 719 397 $ | 2024-04-29 | |
HEARTBEAM, INC.
0.01% | 2023-08-19 | 3,911 ( 0.01% ) | 7 689 $ | 2024-04-29 |
Chris Marlett active positions
| Companies | Position | Start |
|---|---|---|
| MDB CAPITAL HOLDINGS, LLC | Chief Executive Officer | 1996-12-31 |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Chief Executive Officer | 1996-12-31 |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Director/Board Member | 2019-03-31 |
Former positions of Chris Marlett
| Companies | Position | End |
|---|---|---|
| CUE BIOPHARMA, INC. | Director/Board Member | 2020-02-08 |
| THE ARENA GROUP HOLDINGS, INC. | Chief Executive Officer | 2016-11-03 |
| Orion Acquisition Corp. II | Director/Board Member | 2005-05-19 |
| PatentVest, Inc. | Founder | - |
Training of Chris Marlett
| University of Southern California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| THE ARENA GROUP HOLDINGS, INC. | Technology Services |
| CUE BIOPHARMA, INC. | Health Technology |
| MDB CAPITAL HOLDINGS, LLC | Finance |
| Private companies | 4 |
|---|---|
| Orion Acquisition Corp. II | Finance |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
| PatentVest, Inc. | |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |
- Stock Market
- Insiders
- Chris Marlett